**Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program
Professor Michael Kidd, Australia's Chief Medical Officer, said: Some of these products have not undergone sufficient human clinical trials and may cause significant harm
Gastric Emptying Scintigraphy (GES): Considered the gold standard
This product is distinguished by its extensive testing for purity and safety, containing 1000mg of Vitamin C to further support skin whitening, firmness, and rejuvenation
Small, protein-rich meals spread throughout the day are better than sporadic eating patterns
What should I avoid while using Emgality